Adhesive Bifidobacterium Induced Changes in Cecal Microbiome Alleviated Constipation in Mice/Experiment 16
From BugSigDB
Reviewed Marked as Reviewed by KateRasheed on 2025-7-8
Subjects
- Location of subjects
- China
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Mus musculus
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces , Caecum Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces,Blind intestine,Blindgut,Caeca,Caecum,Ceca,Cecum,Intestinum caecum,Intestinum crassum caecum,Intestinum crassum cecum,caecum
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Sampling site Sampling site,sampling site
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- CMB2 (Constipation mice treated with CMB2 with no adhesion properties) (fecal sample)
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- C-CMB2 (Constipation mice treated with CMB2 with no adhesion properties) (cecal sample)
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- This group was intragastrically administered 0.25 mL of normal saline solution containing 4 × 10^10 CFU/mL CMB2(Combined multiple strains of Bifidobacterium with no adhesion property), respectively, daily for 2 weeks and loperamide (0.25 mL) intragastrically from day 15 to day 17 to induce constipation.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 8
- Group 1 sample size Number of subjects in the case (exposed) group
- 8
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- log transformation
- Statistical test
- ANOVA
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
Signature 1
Reviewed Marked as Reviewed by KateRasheed on 2025-7-8
Source: Figure 9,10,11
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: increased abundance in C-CMB2 (Constipation mice treated with CMB2 with no adhesion properties) (cecal sample)
| NCBI | Quality Control | Links |
|---|---|---|
| Akkermansia | ||
| Anaeroplasma | ||
| Clostridium | ||
| Dorea | ||
| Mucispirillum | ||
| Oscillospira | ||
| Parabacteroides | ||
| Rikenella | ||
| Ruminococcus | ||
| unclassified Lachnospiraceae | ||
| unclassified Helicobacteraceae |
Signature 2
Reviewed Marked as Reviewed by KateRasheed on 2025-7-8
Source: Figure 9,10,11
Description: The genus-level comparison of fecal samples and caecum content samples.
Abundance in Group 1: decreased abundance in C-CMB2 (Constipation mice treated with CMB2 with no adhesion properties) (cecal sample)
| NCBI | Quality Control | Links |
|---|---|---|
| Bifidobacterium | ||
| Lactobacillus | ||
| Odoribacter |
Revision editor(s): Mautin
